Rate of cardiac tamponade and/or pericardiocentesis following atrial fibrillation ablation. This measure is submitted as four rates stratified by age and gender:
- Submission Age Criteria 1: Females 18-64 years of age
- Submission Age Criteria 2: Males 18-64 years of age
- Submission Age Criteria 3: Females 65 years of age and older
- Submission Age Criteria 4: Males 65 years of age and older
This measure is to be submitted a minimum of once per performance period for patients with atrial fibrillation ablation performed during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.
NOTE: Include only patients that have had atrial fibrillation ablation performed by November 30, 2018, for evaluation of cardiac tamponade and/or pericardiocentesis occurring within 30 days within the performance period. This will allow the evaluation of cardiac tamponade and/or pericardiocentesis complications within the performance period. A minimum of 30 cases is recommended by the measure owner to ensure a volume of data that accurately reflects provider performance; however, this minimum number is not required for purposes of QPP submission.
This measure will be calculated with 5 performance rates:
- Females 18-64 years of age
- Males 18-64 years of age
- Females 65 years of age and older
- Males 65 years of age and older
- Overall percentage of patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days
MIPS eligible clinicians should continue to submit the measure as specified, with no additional steps needed to account for multiple performance rates.
The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality-data codes listed do not need to be submitted by MIPS eligible clinicians, groups, or third party intermediaries that utilize this modality for submissions; however, these codes may be submitted for those third party intermediaries that utilize Medicare Part B claims data.
The number of patients from the denominator with cardiac tamponade and/or pericardiocentesis occurring within 30 days following atrial fibrillation ablation
The PDC is calculated as follows:
INVERSE MEASURE – A lower calculated performance rate for this measure indicates better clinical care or control. The “Performance Not Met” numerator option for this measure is the representation of the better clinical quality or control. Submitting that numerator option will produce a performance rate that trends closer to 0%, as quality increases. For inverse measures, a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control.
Numerator Quality-Data Coding Options
Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days (G9408)
Performance Not Met:
Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days (G9409)
All patients aged 18 years and older with atrial fibrillation ablation performed during the reporting period
Denominator Criteria (Eligible Cases):
SUBMISSION CRITERIA 1: Females 18-64 years old
SUBMISSION CRITERIA 2: Males 18-64 years old
SUBMISSION CRITERIA 3: Females 65 years of age and older
SUBMISSION CRITERIA 4: Males 65 years of age and older
Diagnosis code for atrial fibrillation (ICD-10-CM): I48.0, I48.1, I48.2, I48.91
Procedure code for atrial fibrillation ablation (ICD-10-PCS): 02583ZZ, 02584ZZ
Ablation procedures that have been performed by November 30 of current performance period (CPT): 93655, 93656, 93657